Burcin Beken1, Riza Serttas2, Mehtap Yazicioglu1, Kader Turkekul2, Suat Erdogan2. 1. Department of Pediatric Allergy and Immunology, School of Medicine, Trakya University, Edirne, Turkey. 2. Department of Medical Biology, School of Medicine, Trakya University, Edirne, Turkey.
Abstract
Background: Atopic dermatitis (AD) is a common inflammatory skin disease with complex pathogenesis. Natural flavonoids exhibit strong anti-inflammatory and antioxidant properties in many human diseases. In this study, the potential bioactive effect of quercetin, a polyphenolic plant-derived flavonoid, on the AD model of human keratinocytes was evaluated. Methods: Immortalized human HaCaT keratinocytes were treated with interleukin (IL) -4, -13, and tumor necrosis factor-α to mimic AD features in vitro. Then effects of quercetin on inflammation, oxidative stress, and wound healing were assessed. Results: Pretreatment of the cells with 1.5 μM of quercetin significantly reduced the expression of AD-induced IL-1β, IL-6, IL-8, and thymic stromal lymphopoietin, while it strongly enhanced the expression of superoxide dismutase-1 (SOD1), SOD2, catalase, glutathione peroxidase, and IL-10. Quercetin promoted wound healing by inducing epithelial-mesenchymal transition, which was supported by the upregulation of Twist and Snail mRNA expression. Unexpectedly, quercetin pretreatment of AD-induced cells upregulated the mRNA expression of occludin and E-cadherin, while downregulating matrix metalloproteinase 1 (MMP1), MMP2, and MMP9 expression. The pretreatment inhibited AD-induced phosphorylation of extracellular signal-regulated kinase 1/2/mitogen-activated protein kinase (ERK1/2 MAPK) and the expression of nuclear factor-kappa B (NF-κB), but it did not alter signal transducer and activator of transcription 6 (STAT6) phosphorylation. Conclusion: Quercetin may serve as a potential bioactive substance for atopic dermatitis-related symptoms through anti-inflammatory and antioxidant activities along with its acceleration of wound healing via ERK1/2 MAPK and NF-κB pathways.
Background: Atopic dermatitis (AD) is a common inflammatory skin disease with complex pathogenesis. Natural flavonoids exhibit strong anti-inflammatory and antioxidant properties in many human diseases. In this study, the potential bioactive effect of quercetin, a polyphenolic plant-derived flavonoid, on the AD model of human keratinocytes was evaluated. Methods: Immortalized human HaCaT keratinocytes were treated with interleukin (IL) -4, -13, and tumor necrosis factor-α to mimic AD features in vitro. Then effects of quercetin on inflammation, oxidative stress, and wound healing were assessed. Results: Pretreatment of the cells with 1.5 μM of quercetin significantly reduced the expression of AD-induced IL-1β, IL-6, IL-8, and thymic stromal lymphopoietin, while it strongly enhanced the expression of superoxide dismutase-1 (SOD1), SOD2, catalase, glutathione peroxidase, and IL-10. Quercetin promoted wound healing by inducing epithelial-mesenchymal transition, which was supported by the upregulation of Twist and Snail mRNA expression. Unexpectedly, quercetin pretreatment of AD-induced cells upregulated the mRNA expression of occludin and E-cadherin, while downregulating matrix metalloproteinase 1 (MMP1), MMP2, and MMP9 expression. The pretreatment inhibited AD-induced phosphorylation of extracellular signal-regulated kinase 1/2/mitogen-activated protein kinase (ERK1/2 MAPK) and the expression of nuclear factor-kappa B (NF-κB), but it did not alter signal transducer and activator of transcription 6 (STAT6) phosphorylation. Conclusion: Quercetin may serve as a potential bioactive substance for atopic dermatitis-related symptoms through anti-inflammatory and antioxidant activities along with its acceleration of wound healing via ERK1/2 MAPK and NF-κB pathways.
Authors: Ana P M Serezani; Gunseli Bozdogan; Sarita Sehra; Daniel Walsh; Purna Krishnamurthy; Elizabeth A Sierra Potchanant; Grzegorz Nalepa; Shreevrat Goenka; Matthew J Turner; Dan F Spandau; Mark H Kaplan Journal: J Allergy Clin Immunol Date: 2016-08-20 Impact factor: 10.793
Authors: Michael J Cork; Simon G Danby; Yiannis Vasilopoulos; Jonathan Hadgraft; Majella E Lane; Manar Moustafa; Richard H Guy; Alice L Macgowan; Rachid Tazi-Ahnini; Simon J Ward Journal: J Invest Dermatol Date: 2009-06-04 Impact factor: 8.551
Authors: Hae Nim Lee; Seong Ah Shin; Gang Sik Choo; Hyeong Jin Kim; Young Seok Park; Byeong Soo Kim; Sang Ki Kim; Sung Dae Cho; Jeong Seok Nam; Chang Sun Choi; Jeong Hwan Che; Byung Kwon Park; Ji Youn Jung Journal: Int J Mol Med Date: 2017-11-29 Impact factor: 4.101
Authors: Michael D Howell; Byung Eui Kim; Peisong Gao; Audrey V Grant; Mark Boguniewicz; Anna Debenedetto; Lynda Schneider; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2007-05-23 Impact factor: 10.793